Yoder KK, Hutchins GD, Mocka BH, et al. Dopamin transporter binding in rat striatum: a comparison of [O-methyl-11C]β-CFT and [N-methyl-11C] β-CFT [J]. Nucl Med Biol, 2009, 36: 11-16.
[2]
Kawamura K, Oda K, Ishiwata K. Age-related changes of the [11C]CFT binding to the striatal dopamine transporters in the fischer 344 rats: a PET study [J]. Ann Nucl Med, 2003, 17: 249-53.
[3]
Rinne JO, Laihinen A, Nagren K, et al. PET examination of the monoamine transporter with [11C]β-CIT and [11C]β-CFT in early Parkinson’s disease[J]. Synapse, 1995, 21: 97-103.
[4]
Haberland N, Hetey L. Studies in postmortem dopamine uptake Ⅱ： Alterations of the synaptosomal catecholamine uptake in postmortem brain regions in schizophrenia[J]. J Neural Transm, 1987, 68: 303-313.
Dannals RF, Neumeyer JL, Milius RA, et al. Synthesis of a radiotracer for studying dopamine uptake sites in vivo using PET: 2β-carbomethoxy-3β-(4-fluorophenyl)[N-11C-methyl]tropane ([11C] CFT or [11C]WIN-35, 428)[J]. J Label Compds Radiopharm, 1993, ⅩⅩⅩⅢ: 147-152.
[7]
Nagren K, Muller L, Halldin C, et al. Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate[J]. Nucl Med Biol, 1995, 22: 235-239.
[8]
Nagren K, Halldin C, Muller L, et al. Comparison of [11C]methyl triflate and [11C]methyl iodide in the synthesis of PET radioligands such as [11C]β-CIT and [11C] β-CFT [J]. Nucl Med Biol, 1995, 22: 965-970.
